APA-Zitierstil (7. Ausg.)

Couillard Castonguay, S., Do, W., Beasley, R., Hinks, T., & Pavord, I. (2022). Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE). European Respiratory Society.

Chicago-Zitierstil (17. Ausg.)

Couillard Castonguay, S., WI Do, R. Beasley, T. Hinks, und I. Pavord. Predicting the Benefits of Type-2 Targeted Anti-inflammatory Treatment with the Prototype OxfoRd Asthma AttaCk Risk ScaLE (ORACLE). European Respiratory Society, 2022.

MLA-Zitierstil (9. Ausg.)

Couillard Castonguay, S., et al. Predicting the Benefits of Type-2 Targeted Anti-inflammatory Treatment with the Prototype OxfoRd Asthma AttaCk Risk ScaLE (ORACLE). European Respiratory Society, 2022.